Back to Agendas
MEDICINES ADAPTIVE PATHWAYS TO PATIENTS (MAPPS) - HOLDING HANDS ACROSS THE LIFECYCLE
Session Chair(s)
James Anderson
Head of Corporate Government Affairs
GlaxoSmithKline, United Kingdom
MAPPs refer to flexible development and access pathways within the current regulatory framework that balance early patient access, public health and societal benefits. To afford patients faster access to innovative medicines a fundamental and co-ordinated change is now required across all elements of the bioscience sector, with collaboration and partnership becoming a core capability for success. The requirements and expectations for sustainable change will be discussed from various perspectives.
Speaker(s)
Presenter
Hans-Georg Eichler, MD, MSc
Austrian Association of Social Security Bodies, Austria
Consulting Physician
Presenter
Gigi Hirsch, MD
Massachusetts Institute of Technology (MIT) Center for Biomedical Innovation, United States
Executive Director
Presenter
Yann Le Cam, MBA
Eurordis-Rare Diseases Europe, France
Chief Executive Officer
Have an account?